Precision Cancer Diagnostic Tests Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1063529
  • May 2021
  • Healthcare
  • 121 Pages
The global Precision Cancer Diagnostic Tests market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Precision Cancer Diagnostic Tests market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Precision Cancer Diagnostic Tests market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Precision Cancer Diagnostic Tests market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Abbott Laboratories, Agilent Technologies Inc., BD, Bio-Rad Laboratories Inc., Biocartis N.V, bioMerieux SA, Danaher Corporation, Hologic Inc., QIAGEN N.V., Thermo Fisher Scientific
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Precision Cancer Diagnostic Tests market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Precision Cancer Diagnostic Tests market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Precision Cancer Diagnostic Tests market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Precision Cancer Diagnostic Tests market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Precision Cancer Diagnostic Tests Market:
The Precision Cancer Diagnostic Tests market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Abbott Laboratories, Agilent Technologies Inc., BD, Bio-Rad Laboratories Inc., Biocartis N.V, bioMerieux SA, Danaher Corporation, Hologic Inc., QIAGEN N.V., Thermo Fisher Scientific

Precision Cancer Diagnostic Tests Market Segment Analysis:
By Product Type
Imaging
Molecular
Tumor Marker Immunoassays
POC Colon Cancer Tests
End User
Hospital
Clinic
Other

Geographic Coverage for Precision Cancer Diagnostic Tests Market:
The market research report on global Precision Cancer Diagnostic Tests market offers complete analysis across various regions across the world. The Precision Cancer Diagnostic Tests market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Precision Cancer Diagnostic Tests market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Precision Cancer Diagnostic Tests Market Value and Forecast
  • US
  • Canada
Europe Precision Cancer Diagnostic Tests Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Precision Cancer Diagnostic Tests Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Precision Cancer Diagnostic Tests Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Precision Cancer Diagnostic Tests Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Precision Cancer Diagnostic Tests market report:
  • The report provides key trends of the global Precision Cancer Diagnostic Tests market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Precision Cancer Diagnostic Tests industry
  • The report covers all the recent developments of the Precision Cancer Diagnostic Tests market and helps to provide current industry updates
  • The report covers a detailed look over the global Precision Cancer Diagnostic Tests Industry and provides with significant actionable insights
  • The Precision Cancer Diagnostic Tests market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Precision Cancer Diagnostic Tests market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Precision Cancer Diagnostic Tests market
  • Comprehensive analysis of the Precision Cancer Diagnostic Tests market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Precision Cancer Diagnostic Tests market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Precision Cancer Diagnostic Tests market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Precision Cancer Diagnostic Tests market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Precision Cancer Diagnostic Tests market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Precision Cancer Diagnostic Tests market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • BD
  • Bio-Rad Laboratories Inc.
  • Biocartis N.V
  • bioMerieux SA
  • Danaher Corporation
  • Hologic Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific
  • Imaging
  • Molecular
  • Tumor Marker Immunoassays
  • POC Colon Cancer Tests
  • Hospital
  • Clinic
  • Other

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Precision Cancer Diagnostic Tests Market Snapshot
          2.1.1. Global Precision Cancer Diagnostic Tests Market By Product Type,2019
               2.1.1.1.Imaging
               2.1.1.2.Molecular
               2.1.1.3.Tumor Marker Immunoassays
               2.1.1.4.POC Colon Cancer Tests
          2.1.2. Global Precision Cancer Diagnostic Tests Market By End User,2019
               2.1.2.1.Hospital
               2.1.2.2.Clinic
               2.1.2.3.Other
          2.1.3. Global Precision Cancer Diagnostic Tests Market By End-use,2019
          2.1.4. Global Precision Cancer Diagnostic Tests Market By Geography,2019

3. Global Precision Cancer Diagnostic Tests Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Precision Cancer Diagnostic Tests Market Size (US$), By Product Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Product Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Product Type, 2020
     4.2. Global Precision Cancer Diagnostic Tests Market Size (US$), By Product Type, 2018 – 2028

5. Global Precision Cancer Diagnostic Tests Market Size (US$), By End User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End User, 2020
     5.2. Global Precision Cancer Diagnostic Tests Market Size (US$), By End User, 2018 – 2028

6. Global Precision Cancer Diagnostic Tests Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Precision Cancer Diagnostic Tests Market Size (US$), By End-use, 2018 – 2028

7. Global Precision Cancer Diagnostic Tests Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Precision Cancer Diagnostic Tests Market Analysis, 2018 – 2028 
          7.2.1. North America Precision Cancer Diagnostic Tests Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Precision Cancer Diagnostic Tests Market Size (US$), By Product Type, 2018 – 2028
          7.2.3. North America Precision Cancer Diagnostic Tests Market Size (US$), By End User, 2018 – 2028
          7.2.4. North America Precision Cancer Diagnostic Tests Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Precision Cancer Diagnostic Tests Market Analysis, 2018 – 2028 
          7.3.1.  Europe Precision Cancer Diagnostic Tests Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Precision Cancer Diagnostic Tests Market Size (US$), By Product Type, 2018 – 2028
          7.3.3. Europe Precision Cancer Diagnostic Tests Market Size (US$), By End User, 2018 – 2028
          7.3.4. Europe Precision Cancer Diagnostic Tests Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Precision Cancer Diagnostic Tests Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Precision Cancer Diagnostic Tests Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Precision Cancer Diagnostic Tests Market Size (US$), By Product Type, 2018 – 2028
          7.4.3. Asia Pacific Precision Cancer Diagnostic Tests Market Size (US$), By End User, 2018 – 2028
          7.4.4. Asia Pacific Precision Cancer Diagnostic Tests Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Precision Cancer Diagnostic Tests Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Precision Cancer Diagnostic Tests Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Precision Cancer Diagnostic Tests Market Size (US$), By Product Type, 2018 – 2028
          7.5.3. Latin America Precision Cancer Diagnostic Tests Market Size (US$), By End User, 2018 – 2028
          7.5.4. Latin America Precision Cancer Diagnostic Tests Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Precision Cancer Diagnostic Tests Market Analysis, 2018 – 2028 
          7.6.1.  MEA Precision Cancer Diagnostic Tests Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Precision Cancer Diagnostic Tests Market Size (US$), By Product Type, 2018 – 2028
          7.6.3. MEA Precision Cancer Diagnostic Tests Market Size (US$), By End User, 2018 – 2028
          7.6.4. MEA Precision Cancer Diagnostic Tests Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Precision Cancer Diagnostic Tests Providers
        8.4.1 Abbott Laboratories
                8.4.1.1 Business Description
                8.4.1.2 Abbott Laboratories Geographic Operations
                8.4.1.3 Abbott Laboratories Financial Information
                8.4.1.4 Abbott Laboratories Product Positions/Portfolio
                8.4.1.5 Abbott Laboratories Key Developments
        8.4.2 Agilent Technologies Inc.
                8.4.2.1 Business Description
                8.4.2.2 Agilent Technologies Inc. Geographic Operations
                8.4.2.3 Agilent Technologies Inc. Financial Information
                8.4.2.4 Agilent Technologies Inc. Product Positions/Portfolio
                8.4.2.5 Agilent Technologies Inc. Key Developments
        8.4.3 BD
                8.4.3.1 Business Description
                8.4.3.2 BD Geographic Operations
                8.4.3.3 BD Financial Information
                8.4.3.4 BD Product Positions/Portfolio
                8.4.3.5 BD Key Developments
        8.4.4 Bio-Rad Laboratories Inc.
                8.4.4.1 Business Description
                8.4.4.2 Bio-Rad Laboratories Inc. Geographic Operations
                8.4.4.3 Bio-Rad Laboratories Inc. Financial Information
                8.4.4.4 Bio-Rad Laboratories Inc. Product Positions/Portfolio
                8.4.4.5 Bio-Rad Laboratories Inc. Key Developments
        8.4.5 Biocartis N.V
                8.4.5.1 Business Description
                8.4.5.2 Biocartis N.V Geographic Operations
                8.4.5.3 Biocartis N.V Financial Information
                8.4.5.4 Biocartis N.V Product Positions/Portfolio
                8.4.5.5 Biocartis N.V Key Developments
        8.4.6 bioMerieux SA
                8.4.6.1 Business Description
                8.4.6.2 bioMerieux SA Geographic Operations
                8.4.6.3 bioMerieux SA Financial Information
                8.4.6.4 bioMerieux SA Product Positions/Portfolio
                8.4.6.5 bioMerieux SA Key Developments
        8.4.7 Danaher Corporation
                8.4.7.1 Business Description
                8.4.7.2 Danaher Corporation Geographic Operations
                8.4.7.3 Danaher Corporation Financial Information
                8.4.7.4 Danaher Corporation Product Positions/Portfolio
                8.4.7.5 Danaher Corporation Key Developments
        8.4.8 Hologic Inc.
                8.4.8.1 Business Description
                8.4.8.2 Hologic Inc. Geographic Operations
                8.4.8.3 Hologic Inc. Financial Information
                8.4.8.4 Hologic Inc. Product Positions/Portfolio
                8.4.8.5 Hologic Inc. Key Developments
        8.4.9 QIAGEN N.V.
                8.4.9.1 Business Description
                8.4.9.2 QIAGEN N.V. Geographic Operations
                8.4.9.3 QIAGEN N.V. Financial Information
                8.4.9.4 QIAGEN N.V. Product Positions/Portfolio
                8.4.9.5 QIAGEN N.V. Key Developments
        8.4.10 Thermo Fisher Scientific
                8.4.10.1 Business Description
                8.4.10.2 Thermo Fisher Scientific Geographic Operations
                8.4.10.3 Thermo Fisher Scientific Financial Information
                8.4.10.4 Thermo Fisher Scientific Product Positions/Portfolio
                8.4.10.5 Thermo Fisher Scientific Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Precision Cancer Diagnostic Tests Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Precision Cancer Diagnostic Tests Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Precision Cancer Diagnostic Tests Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Precision Cancer Diagnostic Tests Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Precision Cancer Diagnostic Tests Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Precision Cancer Diagnostic Tests Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Precision Cancer Diagnostic Tests Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Precision Cancer Diagnostic Tests Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Precision Cancer Diagnostic Tests Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Precision Cancer Diagnostic Tests Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Precision Cancer Diagnostic Tests Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Precision Cancer Diagnostic Tests Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Precision Cancer Diagnostic Tests Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Precision Cancer Diagnostic Tests Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Precision Cancer Diagnostic Tests Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Precision Cancer Diagnostic Tests Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Precision Cancer Diagnostic Tests: Market Segmentation 
FIG. 2 Global Precision Cancer Diagnostic Tests Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Precision Cancer Diagnostic Tests Market, By Product Type, 2019 (US$ Mn) 
FIG. 5 Global Precision Cancer Diagnostic Tests Market, By End User, 2019 (US$ Mn) 
FIG. 6 Global Precision Cancer Diagnostic Tests Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Precision Cancer Diagnostic Tests Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Precision Cancer Diagnostic Tests Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Precision Cancer Diagnostic Tests Providers, 2019
FIG. 11 Global Precision Cancer Diagnostic Tests Market Revenue Contribution, By Product Type, 2019 & 2028 (Value %) 
FIG. 12 Global Precision Cancer Diagnostic Tests Market Revenue Contribution, By End User, 2019 & 2028 (Value %) 
FIG. 13 Global Precision Cancer Diagnostic Tests Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Precision Cancer Diagnostic Tests Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Precision Cancer Diagnostic Tests Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Precision Cancer Diagnostic Tests Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Precision Cancer Diagnostic Tests Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Precision Cancer Diagnostic Tests Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Precision Cancer Diagnostic Tests market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Precision Cancer Diagnostic Tests Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Precision Cancer Diagnostic Tests Market Value, By Segment1, 2018 – 2028
TABLE  North America Precision Cancer Diagnostic Tests Market Value, By Segment2, 2018 – 2028
TABLE  North America Precision Cancer Diagnostic Tests Market Value, By Country, 2018 – 2028
TABLE  Europe Precision Cancer Diagnostic Tests Market Value, By Segment1, 2018 – 2028
TABLE  Europe Precision Cancer Diagnostic Tests Market Value, By Segment2, 2018 – 2028
TABLE  Europe Precision Cancer Diagnostic Tests Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Precision Cancer Diagnostic Tests Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Precision Cancer Diagnostic Tests Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Precision Cancer Diagnostic Tests Market Value, By Country, 2018 – 2028
TABLE  Latin America Precision Cancer Diagnostic Tests Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Precision Cancer Diagnostic Tests Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Precision Cancer Diagnostic Tests Market Value, By Country, 2018 – 2028
TABLE  MEA Precision Cancer Diagnostic Tests Market Value, By Segment1, 2018 – 2028
TABLE  MEA Precision Cancer Diagnostic Tests Market Value, By Segment2, 2018 – 2028
TABLE  MEA Precision Cancer Diagnostic Tests Market Value, By Country, 2018 – 2028
TABLE  Abbott Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Agilent Technologies Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BD: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bio-Rad Laboratories Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biocartis N.V: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  bioMerieux SA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Danaher Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hologic Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  QIAGEN N.V.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Thermo Fisher Scientific: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Precision Cancer Diagnostic Tests Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Precision Cancer Diagnostic Tests Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Precision Cancer Diagnostic Tests Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Precision Cancer Diagnostic Tests Market, By Geography, 2019 (US$ Mn)
FIG.  Global Precision Cancer Diagnostic Tests Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Precision Cancer Diagnostic Tests Providers, 2016
FIG.  Global Precision Cancer Diagnostic Tests Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Molecular Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Tumor Marker Immunoassays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global POC Colon Cancer Tests Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Precision Cancer Diagnostic Tests Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Clinic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Other Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Precision Cancer Diagnostic Tests Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Precision Cancer Diagnostic Tests Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Precision Cancer Diagnostic Tests Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Precision Cancer Diagnostic Tests Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Precision Cancer Diagnostic Tests Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Precision Cancer Diagnostic Tests Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Precision Cancer Diagnostic Tests Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Precision Cancer Diagnostic Tests Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Precision Cancer Diagnostic Tests Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Precision Cancer Diagnostic Tests Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Precision Cancer Diagnostic Tests Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Precision Cancer Diagnostic Tests Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Precision Cancer Diagnostic Tests Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Precision Cancer Diagnostic Tests Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Precision Cancer Diagnostic Tests Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Precision Cancer Diagnostic Tests Market Value, 2018 – 2028, (US$ Mn)